Category Archives: BioUtah News
Scientia Raises $50M to Develop Devices for Stroke, Cancer Treatment
Scientia announced it has raised $50M in growth equity financing from Vivo Capital, a Palo Alto, CA-headquartered global healthcare investment firm. The financing will be used to accelerate sales, marketing, and new product development in both its core neurovascular stroke market as well as adjacent markets in peripheral vascular and interventional oncology. “We are excited […]
Utah #1 For Best State Economic Outlook…Again
Utah has done it again! The 2021 “Rich States, Poor States” report recently released by the American Legislative Exchange Council (ALEC) ranks Utah as the state with the strongest economic outlook in the nation. Utah has held this first place designation for the past 14 years. View state-by-state data HERE. To determine its rankings, the […]
Utility Study Indicates KidneyIntelX Risk Assessment can Address Treatment Ambiguity in Primary Care
RenalytixA has announced results from a new utility study. The study confirms the importance of risk assessment testing in addressing treatment ambiguity in the early stages of diabetic kidney disease (DKD) and improving patient engagement and adherence – two major barriers to slowing or preventing DKD progression and preserving kidney health. In clinical studies, KidneyIntelX […]
Known Medicine Shows Its BioHive Pride
Known Medicine is creating the world’s largest purpose-built 3D cell culture data set to predict the best drug for every cancer patient and create the best drug for every cancer. From patient tumor samples the company generates hundreds of micro-tumors on our proprietary platform and treat them with an extensive panel of drugs or drug […]
Turner Imaging Systems Receives CE Mark for Smart-C ® Mini C-Arm Portable Fluoroscopy X-Ray Imaging Device
Turner Imaging Systems has received its CE Mark for its Smart-C ® Mini C-Arm portable fluoroscopy x-ray imaging device. This will allow the Smart-C, the world’s first highly portable mini c-arm, to be distributed throughout the EU countries as well as the UK. “Securing the CE Mark is a critical regulatory milestone and major step […]
Foldax Announces Successful First Human Use of Tria Biopolymer Mitral Heart Valve
Foldax has announced that it has successfully performed the first-in-man Tria Mitral Valve implant. This is another milestone for the Tria LifePolymer valve platform. Strategically, the mitral valve addresses an unmet global need for a more durable mitral valve that doesn’t require lifetime anticoagulants. This is especially important in the many areas where rheumatic fever […]
Xenter, Inc. Continues Rapid Expansion with Appointment of Scott Heuler, SVP of Global Sales and Marketing, and Gary Baldwin as CTO
On the heels of last week’s announcement of the closing of its $12M Series A offering, Xenter, Inc. has announced the appointment of Scott Heuler as Senior Vice President of Global Sales & Marketing and Gary Baldwin as Chief Technology Officer in its Hospital Technologies business unit. Xenter is innovating new wireless technologies and techniques for […]
Transit Scientific’s XO Score Scoring Sheath Platform Wins Medical Design Award
Transit Scientific”s XO Score Scoring Sheath Platform has been named a winner in the 2021 Medical Design Excellence Awards (MDEA). The MDEA is a premier design competition in the medtech industry, recognizing significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility. Recently, the company received European CE Mark […]
Transit Scientific’s Cutting-Edge Scoring Sheath Platform Earns CE Mark Approval
Transit Scientific has announced that its XO Score® Scoring Sheath Platform has received CE Mark clearance in the European Union for treatment of peripheral artery disease and end stage renal disease. Last year, the company announced FDA clearance for the device. We’ve been thrilled to see the effective low-pressure dilatation and luminal gain achieved using our […]
Clene Nanomedicne Receives Healthy Longevity Catalyst Award
Clene Inc. announced on Monday that the company received a Healthy Longevity Catalyst Award from the U.S. National Academy of Medicine (NAM) to accelerate the preclinical development of CNM-Au8, a bioenergetic nanocatalyst, for treatment of neuronal aging-related deficits and Alzheimer’s disease. The international award will fund preclinical study of CNM-Au8 nanocatalysis for the improvement of human health […]
ARUP Announces Partnership with TellBio for Use of TellBio’s Novel Circulating Tumor Cells Technology
ARUP Laboratories on May 10 announced it has signed a strategic agreement with Massachusetts-based TellBio Inc. to use the company’s TellDx circulating tumor cells (CTCs) technology in several research applications. ARUP has also invested in TellBio as part of the startup’s series A financing round. Other funding partners include Crocker Ventures, Genetron Holdings Ltd (NASDAQ: […]
Xenter Closes Series A at $12M; Adds Four Additional Board Members
Xenter has announced the appointment of four additional industry leaders to its Board of Directors and the closing of a $12M Series A offering of preferred stock. “Xenter is transforming healthcare as an innovative Device-Data-Drug healthcare technologies startup,” said Kelvyn Cullimore, president and CEO of BioUtah. “The new additions to the board, including Utah life […]
